Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer

Gastrointestinal Endoscopy

Volumn 67, Issue 2, 2008, Pages 193-198

  Eloubeidi, Mohamad A ^a   Desmond, Renee ^a   Desai, Shilpa ^a   Mehra, Mohit ^a   Bryant, Ayesha ^a   Cerfolio, Robert J ^a  

^a Department of Pharmacology and Toxicology and Mass Spectrometry Core Facility   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL TIME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADRENAL GLANDS; AGED; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; ENDOSONOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 38349184397     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.06.052     Document Type: Article

References (19)

1. Suzuki K., Nagai K., Yoshida J., et al. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer 86 (1999) 1976-1984
2. Silvestri G.A., Tanoue L.T., Margolis M.L., et al. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 123 (2003) 147S-156S
3. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
4. Fossella F.V., Rivera E., and Roth J.A. Preoperative chemotherapy for stage IIIa non-small cell lung cancer. Curr Opin Oncol 8 (1996) 106-111
5. Rosell R., Gomez-Codina J., Camps C., et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26 (1999) 7-14
6. Roth J.A., Atkinson E.N., Fossella F., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
7. Detterbeck F.C., DeCamp Jr. M.M., Kohman L.J., et al. Lung cancer. Invasive staging: the guidelines. Chest 123 (2003) 167S-175S
8. Toloza E.M., Harpole L., Detterbeck F., et al. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 157S-166S
9. Eloubeidi M.A., Cerfolio R.J., Chen V.K., et al. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thorac Surg 79 (2005) 263-268
10. Eloubeidi M.A., Tamhane A., Chen V.K., et al. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy. Ann Thorac Surg 80 (2005) 1231-1239
11. Mountain C.F. The international system for staging lung cancer. Semin Surg Oncol 18 (2000) 106-115
12. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
13. Myrdal G., Lambe M., Gustafsson G., et al. Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics. Ann Thorac Surg 75 (2003) 356-363
14. Suzuki K., Nagai K., Yoshida J., et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 117 (1999) 593-598
15. Eloubeidi M.A., Seewald S., Tamhane A., et al. EUS-guided FNA of the left adrenal gland in patients with thoracic or GI malignancies. Gastrointest Endosc 59 (2004) 627-633
16. Rosell R., Font A., Pifarre A., et al. The role of induction (neoadjuvant) chemotherapy in stage IIIA NSCLC. Chest 109 Suppl 5 (1996) 102S-106S
17. Varadarajulu S., and Eloubeidi M. Can endoscopic ultrasonography-guided fine-needle aspiration predict response to chemoradiation in non-small cell lung cancer? A pilot study. Respiration 73 (2006) 213-220
18. Aabakken L., Silvestri G.A., Hawes R., et al. Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy. Endoscopy 31 (1999) 707-711
19. Wiersema M.J., Edell E.S., Midthun D.E., et al. Prospective comparison of transbronchial needle aspiration biopsy (TBNA) and endosonography guided biopsy (EUS-FNA) of mediastinal lymph nodes in patients with known or suspected non-small cell lung cancer. [abstract]. Gastrointest Endosc 55 (2000) AB79